At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 16:16 ET
Jim Wassil, an officer of Vaxcyte, filed a Form 144 notice of intent to sell 2,250 shares of common stock, with an approximate market value of $139,230. The shares are to be sold through UBS Financial Services on or after November 2, 2026, following the exercise of stock options. This is a relatively small sale relative to the company's $9.9B market cap and the officer's recent selling history, and is consistent with routine insider transactions for tax or diversification purposes.
- Jim Wassil, an officer of Vaxcyte, filed Form 144 to sell 2,250 shares of common stock.
- The proposed sale value is approximately $139,230 based on the filing date.
- The shares were acquired via exercise of stock options on November 2, 2026.
- The sale is to be executed through UBS Financial Services Inc.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access